Overview

A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

Status:
Completed

Trial end date:
2021-04-16

Target enrollment:

Participant gender:

Summary

To demonstrate the therapeutic equivalence and safety of Tretinoin Gel Microsphere, 0.1% (Taro Pharmaceuticals U.S.A, Inc.) and RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% (Valeant) in the treatment of acne vulgaris.

Phase:

Early Phase 1

Details

Lead Sponsor:

Taro Pharmaceuticals USA

Treatments:

Tretinoin